https://www.selleckchem.com/pr....oducts/marimastat.ht
CPFA is an extracorporeal treatment used in severe sepsis to remove circulating proinflammatory cytokines. Limited evidence exists on the effectiveness of bilirubin adsorption by the hydrophobic styrenic resin, the distinctive part of CPFA. The aim of this study is to validate CPFA effectiveness in liver detoxification. In this prospective observational study, we enrolled patients with acute or acute-on-chronic liver failure (serum total bilirubin 20mg/dL or MELD Score 2 hospitalized from June 2013 to November 2017. CPFA
Like
Comment
Share
